Centralization of care for patients with advanced‐stage ovarian cancer
- 12 March 2007
- Vol. 109 (8), 1513-1522
- https://doi.org/10.1002/cncr.22561
Abstract
BACKGROUND. The objective of this study was to evaluate the cost‐effectiveness of centralized referral of patients with advanced‐stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy. METHODS. A decision‐analysis model was used to compare 2 referral strategies for patients with advanced‐stage ovarian cancer: 1) referral to an expert center, with a rate of optimal primary cytoreduction of 75% and utilization of combined intraperitoneal and intravenous adjuvant chemotherapy, and 2) referral to a less experienced center, with a rate of optimal primary cytoreduction of 25% and adjuvant treatment that consisted predominantly of intravenous chemotherapy alone. The cost‐effectiveness of each strategy was evaluated from the perspective of society. RESULTS. A cost‐effectiveness analysis revealed that the strategy of expert center referral had an overall cost per patient of $50,652 and had an effectiveness of 5.12 quality‐adjusted life years (QALYs). The strategy of referral to a less experienced center carried an overall cost of $39,957 and had an effectiveness of 2.33 QALYs. The expert center strategy was associated with an additional 2.78 QALYs at an incremental cost of $10,695 but was more cost‐effective, with a cost‐effective ratio of $9893 per QALY compared with $17,149 per QALY for the less experienced center referral strategy. Sensitivity analyses and a Monte Carlo simulation confirmed the robustness of the model. CONCLUSIONS. According to results from the decision‐analysis model, centralized referral of patients with ovarian cancer to an expert center was a cost‐effective healthcare strategy and represents a paradigm for quality cancer care, delivering superior patient outcomes at an economically affordable cost. Increased efforts to align current patterns of care with a universal strategy of centralized expert referral are warranted. Cancer 2007. © 2007 American Cancer Society.Keywords
This publication has 47 references indexed in Scilit:
- Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinomaCancer, 2005
- Ovarian cancer surgery in Maryland: volume-based access to careGynecologic Oncology, 2004
- Cost-effectiveness analyses in gynecologic oncology: methodological quality and trendsGynecologic Oncology, 2004
- Evidence of benefit from centralised treatment of ovarian cancer: A nationwide population‐based survival analysis in FinlandInternational Journal of Cancer, 2002
- What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?BJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: A prospective randomized trialAmerican Journal of Obstetrics and Gynecology, 1996
- Patterns of care in carcinoma of the ovaryCancer, 1993
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective studyGynecologic Oncology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985